Heart Failure Clinical Trial

Nebulized Albuterol for Congestive Heart Failure Exacerbation

Summary

This is a randomized trial of the use of Albuterol in the setting of acute decompensated Congestive Heart Failure with radiographic evidence of Cardiogenic Pulmonary Edema.

View Full Description

Full Description

The objective is to carry out a randomized blinded placebo-controlled trial of inhaled Albuterol as an early therapy for patients with decompensated Congestive Heart Failure. Compared to placebo, inhaled Albuterol will improve oxygenation and decrease the need for non-invasive ventilation in patients with Cardiogenic Pulmonary Edema.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

age 18-65 with shortness of breath and history of CHF
pulmonary edema on chest xr

Exclusion Criteria:

pregnancy
clinical or ekg changes to suggest acute coronary syndrome
history of copd or asthma
history of albuterol on medication list

Study is for people with:

Heart Failure

Phase:

Phase 2

Study ID:

NCT01375361

Recruitment Status:

Withdrawn

Sponsor:

University of California, San Francisco

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of California
San Francisco California, 94143, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Phase:

Phase 2

Study ID:

NCT01375361

Recruitment Status:

Withdrawn

Sponsor:


University of California, San Francisco

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider